The potential role of telemedicine in the infectious disease pandemic with an emphasis on COVID-19: A narrative review.
COVID‐19
health systems
infectious disease pandemic
telemedicine
Journal
Health science reports
ISSN: 2398-8835
Titre abrégé: Health Sci Rep
Pays: United States
ID NLM: 101728855
Informations de publication
Date de publication:
Jan 2023
Jan 2023
Historique:
received:
22
06
2022
revised:
14
12
2022
accepted:
14
12
2022
entrez:
9
1
2023
pubmed:
10
1
2023
medline:
10
1
2023
Statut:
epublish
Résumé
Due of its low cost, rapid speed, data record, and vast communication coverage, information and communication technology might be useful for health-related fields in times of crisis. By providing medical or hygienic services to a patient who lives elsewhere using communication methods like email, fax, cellphones, applications, and wireless gadgets, telemedicine can aid in the better management of diseases. Reviewing the potential role of telemedicine in the pandemic of infectious diseases with a focus on the Coronavirus disease 2019 (COVID-19) epidemic was the main goal of this study. "Google Scholar," "PubMed," "Science Direct," and "Scopus" databases were searched to collect the papers that identify the advantages and disadvantages of telemedicine in the disease pandemic. Searched keywords include: telepharmacy, telemedicine, remote communication, pandemic(s), epidemic, distant care, distant communication, phone consulation, video conference communication and patient education. Information and communication technology are crucial, especially when dealing with pandemics of infectious diseases like COVID-19. Less "in-person" patient visits to hospitals as a result of telemedicine eventually means less labor for the medical staff, less viral exposure for patients, and ultimately less disease spread. By establishing a bidirectional reciprocal relationship between patients and healthcare providers although they are in separate geographical areas, it can improve patient health status. Governments are currently facing a significant budgetary burden because to the COVID-19 pandemic. Since patients are not sent to medical facilities in person, which could be a source of infection, telemedicine reduces disease spread while saving money.
Sections du résumé
Background and Aims
UNASSIGNED
Due of its low cost, rapid speed, data record, and vast communication coverage, information and communication technology might be useful for health-related fields in times of crisis. By providing medical or hygienic services to a patient who lives elsewhere using communication methods like email, fax, cellphones, applications, and wireless gadgets, telemedicine can aid in the better management of diseases. Reviewing the potential role of telemedicine in the pandemic of infectious diseases with a focus on the Coronavirus disease 2019 (COVID-19) epidemic was the main goal of this study.
Methods
UNASSIGNED
"Google Scholar," "PubMed," "Science Direct," and "Scopus" databases were searched to collect the papers that identify the advantages and disadvantages of telemedicine in the disease pandemic. Searched keywords include: telepharmacy, telemedicine, remote communication, pandemic(s), epidemic, distant care, distant communication, phone consulation, video conference communication and patient education.
Results
UNASSIGNED
Information and communication technology are crucial, especially when dealing with pandemics of infectious diseases like COVID-19. Less "in-person" patient visits to hospitals as a result of telemedicine eventually means less labor for the medical staff, less viral exposure for patients, and ultimately less disease spread. By establishing a bidirectional reciprocal relationship between patients and healthcare providers although they are in separate geographical areas, it can improve patient health status.
Conclusion
UNASSIGNED
Governments are currently facing a significant budgetary burden because to the COVID-19 pandemic. Since patients are not sent to medical facilities in person, which could be a source of infection, telemedicine reduces disease spread while saving money.
Identifiants
pubmed: 36620507
doi: 10.1002/hsr2.1024
pii: HSR21024
pmc: PMC9811063
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e1024Informations de copyright
© 2023 The Authors. Health Science Reports published by Wiley Periodicals LLC.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
J Clin Lab Anal. 2022 May;36(5):e24426
pubmed: 35435264
Integr Pharm Res Pract. 2016 Oct 26;5:75-82
pubmed: 29354542
Consult Pharm. 2017 Feb 1;32(2):93-98
pubmed: 28569660
Front Med (Lausanne). 2021 Jul 06;8:646506
pubmed: 34295908
J Pharm Technol. 2020 Oct;36(5):171-178
pubmed: 34752571
J Telemed Telecare. 2020 Jun;26(5):309-313
pubmed: 32196391
Int J Environ Res Public Health. 2021 Jul 19;18(14):
pubmed: 34300110
Digit Health. 2018 Jul 26;4:2055207618789322
pubmed: 30083373
Am J Health Syst Pharm. 2008 Aug 1;65(15):1464-9
pubmed: 18653818
Chron Respir Dis. 2016 May;13(2):192-203
pubmed: 26902542
Med J Islam Repub Iran. 2022 Jun 22;36:68
pubmed: 36128316
Am J Health Syst Pharm. 2013 Nov 1;70(21):1875-6
pubmed: 24128957
Am J Health Syst Pharm. 2018 Oct 1;75(19):1493-1517
pubmed: 30257844
Crit Care Clin. 2022 Oct;38(4):809-826
pubmed: 36162912
J Telemed Telecare. 2020 Jan-Feb;26(1-2):105-112
pubmed: 30253681
Pharm Pract (Granada). 2017 Oct-Dec;15(4):1134
pubmed: 29317927
Am J Health Syst Pharm. 2017 May 1;74(9):e236-e241
pubmed: 28438829
Int J Pharm Pract. 2017 Jun;25(3):210-219
pubmed: 28466547
Sens Int. 2021;2:100117
pubmed: 34806053
Int J Integr Care. 2022 Aug 08;22(3):4
pubmed: 36043030
Telemed J E Health. 2022 Jun 27;:
pubmed: 35758766
Ann Transl Med. 2020 May;8(10):626
pubmed: 32566563
J Clin Lab Anal. 2022 May;36(5):e24402
pubmed: 35396748
Aten Primaria. 2020 Jun - Jul;52(6):418-422
pubmed: 32402477
Global Spine J. 2021 Jun 14;:21925682211022311
pubmed: 34121482
Health Policy Technol. 2020 Sep;9(3):368-371
pubmed: 32837888
J Asthma. 2017 Nov;54(9):961-967
pubmed: 28095068
Telemed J E Health. 2012 Sep;18(7):530-7
pubmed: 22822940
PLoS One. 2011 Jan 21;6(1):e14515
pubmed: 21283736
Perspect Health Inf Manag. 2014 Apr 01;11:1g
pubmed: 24808808
Front Public Health. 2020 Nov 19;8:531038
pubmed: 33330300
Vacunas. 2022 Sep-Dec;23:S36-S43
pubmed: 35669082
Am J Health Syst Pharm. 2014 Dec 15;71(24):2159-66
pubmed: 25465589
Am J Health Syst Pharm. 2002 Apr 15;59(8):716-21
pubmed: 11977856
Fam Med Community Health. 2020 Aug;8(3):
pubmed: 32816942
Int J Med Inform. 2022 Mar 23;162:104751
pubmed: 35339887
Healthcare (Basel). 2021 Jun 15;9(6):
pubmed: 34203888
J Clin Virol. 2020 May;126:104345
pubmed: 32278298
Ethiop J Health Sci. 2022 May;32(3):485-496
pubmed: 35813682
Pharmacy (Basel). 2021 Oct 01;9(4):
pubmed: 34698254
Digit Health. 2021 Apr 19;7:20552076211009396
pubmed: 33959378
Vacunas. 2022 Aug 30;:
pubmed: 36062028
J Hum Hypertens. 2019 Mar;33(3):177-187
pubmed: 30546052
Pediatr Pulmonol. 2019 Aug;54(8):1216-1224
pubmed: 31066229
Medicina (Kaunas). 2019 Jul 01;55(7):
pubmed: 31266263
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):779-788
pubmed: 32526627
J Telemed Telecare. 2023 Jan;29(1):18-27
pubmed: 33059541
Crit Care Nurse. 2020 Aug 1;40(4):25-31
pubmed: 32464662
Int J Circumpolar Health. 2007;66 Suppl 1:14-22
pubmed: 18154228
BMC Med Inform Decis Mak. 2022 Apr 19;22(1):105
pubmed: 35440082
Am J Health Syst Pharm. 2005 Feb 15;62(4):406-10
pubmed: 15745894
Am J Health Syst Pharm. 2010 Sep 1;67(17):1456-62
pubmed: 20720245
BMC Public Health. 2020 Aug 1;20(1):1193
pubmed: 32738884
Int J Pharm Pract. 2015 Feb;23(1):61-6
pubmed: 24635320
Prim Health Care Res Dev. 2021 Sep 29;22:e48
pubmed: 34583801
Am J Health Syst Pharm. 2010 Dec 1;67(23):2052-7
pubmed: 21098378
Medicare Medicaid Res Rev. 2013 Dec 04;3(4):
pubmed: 24834368
Ann Pharmacother. 2018 Dec;52(12):1250-1258
pubmed: 29984590